“Deborah agreed to take part in a trial as she was keen to help other cancer patients in the future. "If taking part in a trial means others might be helped then I’m very happy with that."
A study looking at why people respond differently to the same chemotherapy (PG SNPS)
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is looking at blood samples from women with breast cancer to see why they have different side effects and results from the same chemotherapy . It is for women who have taken part in one of the breast cancer trials NEAT, McNEAT, tAnGO or Neo-tAnGo. Or, had
Researchers believe that side effects and differences in results could be linked to how your body handles chemotherapy. They will use blood samples to study the characteristics of certain genes that tell your body how to process drugs. They will look at the side effects and treatment outcome of each person in the study. They will build a record (profile) of these results. In future, doctors may be able to look at this record and predict which chemotherapy will work best for a particular person.
You will not have any direct benefit from taking part in this study, and it is unlikely to change your treatment plan. But the results of the study will be used to help people with cancer in the future. The aims of this study are to
- Look at the chemotherapy side effects from these trials, and see how common they are
- Learn more about the genes that may affect side effects and response to chemotherapy
- See how accurate gene profiles are at predicting side effects and treatment outcome
Who can enter
You can enter this study if you
- Have taken part in one of the breast cancer trials NEAT, McNEAT, tAnGO or Neo-tAnGo or
- Have had CMF chemotherapy with epirubicin (E-CMF), with or without a
taxane chemotherapyat a centre in the West Anglia Cancer Research Network (WACRN)
You cannot enter this study if you
- Have not taken part in any of these trials, or the above treatment within the West Anglia Cancer Research Network
This is a national study. It hopes to recruit nearly 5,000 people. Everyone will have one blood test or spit (saliva) test. (Please note: after June 2009 the study teams will stop collecting blood samples, and collect spit samples only).
If you are having chemotherapy, you will give your study blood sample at the same time as your routine pre chemotherapy blood test. So you will not have an extra needle.
If you are not having chemotherapy, you will give your blood sample when you agree to take part in the study, or at your next routine clinic appointment.
If you cannot get to the hospital, it may be possible to give your blood sample at your GP surgery or local hospital. Or instead you may be able to give a spit (saliva) sample at home and return it to the research team by post.
As there are no treatments, there are no side effects. You may have a small bruise where you had your blood test.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Jean Abraham
Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Cambridge